Entrada Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Entrada Therapeutics

13/08/2024 13:36

* Entrada Therapeutics Inc  TRDA.OQ  reported quarterly
adjusted
earnings of $1.55​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -78 cents.  The mean expectation of
five analysts for the quarter was for earnings of 14 cents per
share. Wall Street expected results to range from -41 cents
to 77 cents per share.
    * Revenue rose 421.2% to $94.69 million from a year ago;
analysts
expected $46.08 million. 
    * Entrada Therapeutics Inc's reported EPS for the quarter
was
$1.55​.
    * The company reported quarterly net income of $55.03
million.
    * Entrada Therapeutics Inc shares had fallen by 0.3% this
quarter and lost 5.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Entrada
Therapeutics Inc is $21.50 
This summary was machine generated from LSEG data August 13 at
12:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.15           1.55           Beat
 Mar. 31 2024      -0.59          0.68           Beat
 Dec. 31 2023      -0.17          -0.29          Missed
 Sep. 30 2023      -0.74          1.02           Beat